Arginine kinase (AK) is a member of a highly conserved family of phosphagen kinases. We determined the cDNA sequence of
Toxocara canis AK, cloned it in pMAL plasmid and expressed it in
Escherichia coli as a fusion protein with maltose-binding protein. The protein has a theoretical molecular mass of 45,376 Da and an estimated isoelectric point (p
I) of 8.38. Alignment of the cDNA-derived amino acid sequence of
T. canis AK with other phosphagen kinase sequences showed high amino acid identity with other nematode AKs, and phylogenetic analysis placed it as a distinct branch within a nematode AK cluster. Analysis of the N-terminus sequence of
T. canis AK revealed the presence of a signal targeting peptide presumably targeting this protein to cytosol or endoplasmic reticulum (ER).
T. canis AK showed high activity for
l-arginine. The kinetic constants (
Km = 0.12 mM,
Kcat = 29.18, and
Kd = 0.23 mM) and
Vmax (43.76 μmol Pi/min/mg protein) of
T. canis recombinant-AK were determined for the forward reaction. It also exhibited a synergism for substrate binding
. Comparison of
values in various arginine kinases indicates that
T. canis AK has a high catalytic efficiency (248.19 s
−1 mM
−1). The present study contains the first description of arginine kinase in a zoonotic nematode. The determination of
T. canis AK and its phosphagen biosynthetic pathway, which is completely different from those in mammalian host tissues, suggests this enzyme as a possible novel chemotherapy target for VLM syndrome in humans.